Evidence map›Paper›PMID 23985350›Full record

ArticleBiochemical and biophysical research communications2013

A humanin analog decreases oxidative stress and preserves mitochondrial integrity in cardiac myoblasts.

Laura E Klein, Lingguang Cui, Zhenwei Gong, Kai Su, Radhika Muzumdar

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Humanin and diabetes mellitus: A review ofWorld journal of diabetes · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Laura E KleinDepartment of Pediatrics, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Lingguang Cui
Zhenwei Gong
Kai Su
Radhika Muzumdar
Albert Einstein College of Medicine · US

Funding

Novel Regulators of Glucose Homeostasis in AgingR01AG035114 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MUZUMDAR, RADHIKA HIREN · 2010 to 2014
$1.6M
NIA NIH HHS R01 AG035114
6 · The paper itself

Abstract

A potent analog (HNG) of the endogenous peptide humanin protects against myocardial ischemia-reperfusion (MI-R) injury in vivo, decreasing infarct size and improving cardiac function. Since oxidative stress contributes to the damage from MI-R we tested the hypotheses that: (1) HNG offers cardioprotection through activation of antioxidant defense mechanisms leading to preservation of mitochondrial structure and that, (2) the activity of either of a pair of non-receptor tyrosine kinases, c-Abl and Arg is required for this protection. Rat cardiac myoblasts (H9C2 cells) were exposed to nanomolar concentrations of HNG and to hydrogen peroxide (H2O2). Cells treated with HNG in the presence of H2O2 demonstrated reduced intracellular reactive oxygen species (ROS), preserved mitochondrial membrane potential, ATP levels and mitochondrial structure. HNG induced activation of catalase and glutathione peroxidase (GPx) within 5 min and decreased the ratio of oxidized to reduced glutathione within 30 min. siRNA knockdown of both Abl and Arg, but neither alone, abolished the HNG-mediated reduction of ROS in myoblasts exposed to H2O2. These findings demonstrate an HNG-mediated, Abl- and Arg-dependent, rapid and sustained activation of critical cellular defense systems and attenuation of oxidative stress, providing mechanistic insights into the observed HNG-mediated cardioprotection in vivo.

Indexed as

AnimalsAntioxidantsCatalaseGene Knockdown TechniquesGlutathione PeroxidaseHydrogen PeroxideIntracellular Signaling Peptides and ProteinsMembrane Potential, MitochondrialMitochondriaMyoblasts, CardiacMyocardial Reperfusion InjuryNeuroprotective AgentsOxidative StressPeptidesProtein-Tyrosine KinasesProto-Oncogene Proteins c-ablAntioxidantsARG tyrosine kinaseCatalaseGlutathione PeroxidaseGly(14)-HumaninhumaninHydrogen PeroxideIntracellular Signaling Peptides and ProteinsNeuroprotective AgentsPeptidesProtein-Tyrosine KinasesProto-Oncogene Proteins c-ablReactive Oxygen SpeciesAbelson murine leukemia viral mammalian homologAbl-related gene productArgc-Ablglutathione peroxidaseGPxHNHNGHN in which the serine 14 is replaced by glycineHumaninhumanin, an endogenous 24-amino acid peptideMI–RMitochondriamitochondrial membrane potentialMMPmyocardial ischemia–reperfusionMyocardial ischemia–reperfusionOxidative stressreactive oxygen speciesROSSODsuperoxide dismutase

Identifiers

PMID23985350
PMCPMC3853355
OpenAlexW2041954013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.